Delivering Streamlined Processes and Customer-Centricity in the HLS Industry
Thursday, October 7, 2021 | 2pm BST / 9am ET | FinancialForce

Join this webinar to explore how running a customer-centric organization leads to organisational agility, process efficiency, and ultimately faster speed of innovation. Register now.

Bespoke & flexible cell line development programs from gene to clinic
Thursday, September 23, 2021 | 11am ET / 8am PT | Lonza

To learn how you can chart an optimal path from gene to the clinic by tailoring your cell line development program to match your molecule type, timelines, yield requirements and risk priorities, register for our webinar now.

Not All Elastomeric Component Surface Barriers Are Created Equal
Wednesday, September 22, 2021 | 11am ET / 8am PT | West Pharmaceutical Services

Did you know that not all elastomeric component surface barriers are created equal? Gain insight from West experts, Cathy Zhao and Peggy Frandolig, in a free webinar on September 22. Register Now.

Real-world data to precisely message HCPs across all marketing channels
Wednesday, September 15, 2021 | 1pm ET / 10am PT | Prognos Health

Pharma brand managers have moved from traditional marketing models for many reasons. However, the now favored Omnichannel approach has been difficult to implement because it requires the discipline of a cross-channel strategy that seamlessly integrates content to provide consistency across multiple “buyer” physician touchpoints. This webinar covers how RWD can accelerate executing on a true omnichannel outreach. Register now.

Avoiding pitfalls in sterile manufacturing
Thursday, September 9, 2021 | 11am ET / 8am PT | Grand River Aseptic Manufacturing

While the rapid development of COVID-19 vaccines helped to wind down the pandemic, it also brought to light the many challenges involved in ramping up the production of injectables that must be made in sterile, aseptic environments. Several companies struggled to compress what’s normally a year-long process of getting up to speed into a matter of months. Such pitfalls can be avoided, however, by improving planning processes and adopting new technologies to streamline manufacturing. Register Now.

MDR conform development of sterile Medical Devices
Wednesday, September 1, 2021 | 10am ET / 7am PT | Fresenius Kabi

The Webinar will cover challenges of MDR for sterile medical device manufacturing companies, phases of Design Control for the development process of sterile disposable medical devices, advantages of a one-stop-shop during development and production in MDR environment, and contract Manufacturing partnership. By attending the webinar, you will get insight on MDR requirements and their impact on the development of medical devices, relevance of adequate documentation during MDR conform development of sterile medical devices, and advantages of Contract Manufacturing as strategic partnership to fulfill MDR requirements--especially for pharmaceuticals companies. Register Now.

Preparing for an evolving regulatory landscape to successfully commercialize cell and gene therapies
Tuesday, August 31, 2021 | 11am ET / 8am PT | Thermo Fisher Scientific

Monica Commerford, Ph.D., Head of Regulatory Affairs at Thermo Fisher Scientific, discusses the strategies available to meet critical regulatory requirements to accelerate early to late state CMC product development. Register Now.

Accelerate late-phase drug development with continuous manufacturing
Wednesday, August 25, 2021 | 11am ET / 8am PT | Thermo Fisher Scientific

Continuous manufacturing enables late-phase development by ensuring quality assurance and reducing API usage. Attend this webinar to learn how to create a strategy that reduces total cost of ownership. Register Now.

Today’s View - How patients engage in social networks
Tuesday, August 24, 2021 | 1pm ET / 10am PT | MyHealthTeams

How do today’s patients engage in social networks? Learn what’s working for innovative health marketers as consumers facing chronic health conditions re-think the relationships and resources that help them manage their disease. Register now.

How lessons learned from the COVID pandemic will improve vaccine development in the future
Wednesday, August 11, 2021 11am ET / 8am PT | Catalent

During the COVID-19 pandemic, several pharma companies moved so fast to develop vaccines that the amount of time between the sequencing of the virus to the introduction of the first three vaccines was less than a year. This Fierce webinar will include input from vaccine R&D professionals, including experts in clinical trial design, regulatory affairs and manufacturing. They will draw upon their own experiences in vaccine development to offer tips for incorporating elements of the successful COVID-19 vaccine rollout into future vaccine programs. Register Now.

Navigating the Digital Transformation Journey
LabVantage Solutions, Inc.

Digital transformation is about more than moving from paper to glass. It’s about the way that enterprises use technology and data to build a business ecosystem, thereby reducing risk, accelerating innovation, and driving growth. Navigate your journey with LabVantage. Learn more now.

Get solutions to market faster

Secure regulated and non-regulated content, keep data GxP compliant, and simplify how teams work together. Download eBook now. 

The Future of Clinical Monitoring
Recorded on Wednesday, July 28 | IQVIA

Risk-based, Remote, Centralized Monitoring – all can play a critical role in clinical trials, but which is right for your study? If you are responsible for a clinical trial, leading clinical operations, project management, outsourcing, or clinical monitoring, learn about the breadth of technology choices and what you should consider to determine the ideal solution for your unique study needs. Register now.

COVID-19 Virus Sequencing for Drug Development
Recorded on Wednesday, July 28, 2021 | Labcorp Drug Development

In this webinar, we will establish the medical backdrop for COVID-19 virus sequencing in drug development, connect insights from population surveillance to potential solutions for drug developers, describe the biological relevance of sequencing in drug development, and outline approaches to COVID-19 virus sequencing, including the application of both targeted and whole genome sequencing to drug development. Register now!

How to Optimize In Vitro and In Vivo Data Analysis and Data Management in Drug Research

This whitepaper explores how powerful, fast and modern, modular architecture, combined with interactive data management, visualization and analysis platform can accelerate the entire discovery and research process. This resource is helpful for companies that are looking to help scientists and research IT teams to reclaim months of their time usually spent on manual steps to bridge gaps in their current software or reinventing the wheel while trying to optimize their lab and IT processes. Learn More.

Content Hub: Post-Marketing Safety Studies
Evidera, a PPD business

As the safety landscape evolves and access to RWD expands, an increasing number of products are requiring post-authorization safety studies. Recent white papers explore key post-marketing safety study solutions and provide insights into their successful use in providing real-world safety evidence. Learn more.

New trends in virtual trials
Recorded on Monday, July 26, 2021 | Catalent

In November, clinical trial platform developer Medable raised $91 million in private funding, amid the COVID-19 pandemic that touched off huge demand among pharmaceutical companies looking to initiate “siteless” or virtual clinical trials. This webinar will explore the role of CROs in siteless trials and the opportunities and challenges for CROs to expand their capabilities in this burgeoning area. Register now.

Be a part of shaping the future of Drug Discovery Programs
Fierce Life Sciences Custom Publishing

With the landscape of drug discovery evolving so rapidly the voice of executives and those leading these programs is key in driving efficient and comprehensive drug discovery solutions. Take 5 minutes to complete this short survey, the first 100 qualified respondents will receive a $25 Amazon gift card.

Revolutionizing Commercial Operations: The Power of People, Process, and Technology
Recorded on Thursday, July 22, 2021 | Model N

In today’s complex market, emerging and mid-size pharmaceutical manufacturers require the expertise and supporting technologies, across multiple disciplines, to effectively maximize product revenue and optimize market access functions. Join us on July 22, as industry expert, Tracy Mumpower, shares strategies for integrating a Business Service operations model with your Commercial and Market Access teams, to continue to drive operational excellence and insights through the power of People, Process, and Technology. Register Now.

How Digital Transformation Can Lead the Evolution of Pharmaceutical Operations
Salesforce and Copado

Pharmaceutical companies are continuing to rethink how they develop, make and distribute medicines to position themselves for success in the post-pandemic environment. The pandemic showed they need more nimble technology stacks that enable them to pivot at scale and continue to adapt their operations to challenges and opportunities. Learn how low-code enterprise systems give pharma companies more capability AND more flexibility when combined with modern Development Operations suites and tools. Download now.

Opportunities for Expanding usage of Real-World Data across the Oncology Product Development Life Cycle
Recorded on Thursday, July 15, 2021 | Ontada

Real-world data are currently supporting decision making across the spectrum of oncology care.  Join us as we discuss the current paradigm of oncology product development life cycle and the use of real-world oncology data to drive innovation, efficiencies, and improvements in patient outcomes. Register now.

Five Common Mistakes in Panel Management
Recorded on Wednesday, July 14, 2021 | SurveyHealthcareGlobus

It takes time and focus to keep your panel in good health. By learning common pitfalls, this webinar will assist you in refining your panel management strategy and best practices to keep your respondents motivated and engaged. Register now.

How MOMA Therapeutics Drives World Class Lead Discovery In The Cloud
Recorded on Monday, July 12, 2021 | PerkinElmer

In this webinar hear from “both sides of the house” – first from an innovative information technology leader and then a senior scientist who uses the solutions provided by IT.  Learn how MOMA Therapeutics’ innovative lead discovery solution can be applied to the needs of your biotechnology discovery workflows. Save Your Spot.

Integrating Wearable Biosensor Technologies into Clinical Studies

Wearable biosensors are transforming clinical research to the benefit of patients, sites and sponsors alike. This whitepaper discusses the challenges and considerations Sponsors need to consider before they can realize the promise of wearable biosensors. Download Now.

Integrating Your IRB and IBC Processes to Improve and Accelerate Clinical Trials

The benefits of integrating IRB and IBC review processes were brought to light during the COVID pandemic. Working with an integrated IRB and IBC can streamline study startup for genetic engineering trials. In this whitepaper learn about: an overview of the IRB and IBC, understanding the IBC process, advancing COVID-19 vaccine development through integrated reviews, and the future of gene therapy. Download Now!

Integrating Life Sciences and Digital Technology to Transform Therapeutic Research and Development
Dell Technologies

COVID-19 showed us the potential and need for radical improvement in the life sciences industry. Pandemic programs reset expectations for how quickly drugs and vaccines can reach patients with unprecedented R&D timelines. Changing patient expectations and technology are catching up with industry needs, setting the stage for a period of transformation that will accelerate the development of life-changing medicines. Download now.

Evaluating current manufacturing platforms for recombinant AAV production
Patheon by Thermo Fisher Scientific

Realizing the full potential of viral vector-based therapies requires a successful manufacturing platform for AAV vectors. In this whitepaper, compare differences between AAV platforms and the pros and cons of each to help evaluate which option is best suited for your gene therapy. Download now.

Digital Therapeutics 101
Blue Matter, strategic consultants in the life sciences

E-book to get newcomers “up to speed” quickly on digital health and digital therapeutics while also addressing key issues important to those already familiar with the topic. Download now. 

Strategies for mitigating supply chain risk in clinical trials
Patheon by Thermo Fisher Scientific

It’s time to take a closer look at your supply chain to ensure it delivers with speed, efficiency, and quality — all within budget. This whitepaper will discuss risks associated with supply chain and considerations for deciding the best model to suite your organization’s needs and timeline. Download now.

Going from Process R&D to Clinical APIs Quickly and Effectively
Cascade Chemistry by Aceto

Pharmaceutical companies driving an active ingredient to clinical trials need an API CDMO that overcomes challenges with creative problem-solving and a high level of flexibility. This white paper explores how to move from process R&D to clinical APIs quickly and effectively with the right CDMO. Read More Now.

Implementation Science: A Primer
Evidera, a PPD business

In this new white paper, our experts discuss various implementation science study designs, the role of continuous quality improvement, and share examples of studies that utilized implementation science to optimize product uptake. Read more.

The Interconnected World of Pricing, Market Access, and Value-Based Decision Making
Recorded on Wednesday, June 30, 2021 | Deloitte

Biopharmaceutical drug pricing and market access contracting have become more complicated and interrelated than ever. Join us to discuss how a more integrated, intuitive approach to pricing and contracting can create organizational agility. Discover how this inter-connected approach can have a radical impact on the profitability of life sciences organizations as well as align incentives across the health care ecosystems. Register now.

Advancing Innovative Drug Discovery by DNA Encoded Library and FBDD/SBDD methods
Recorded on Wednesday, June 30, 2021 | HitGen & Vernalis

HitGen has established an industry-leading drug discovery platform for small molecules and nucleic acid drugs centered on the design, synthesis and screening of DNA encoded chemical libraries (DELs), fragment-based drug discovery (FBDD) and structure-based drug design (SBDD) technologies. HitGen founder Dr. Jin Li and Vernalis chief scientist Professor Rod Hubbard will join hands to illustrate advancing innovative drug discovery by DNA Encoded Library and FBDD/SBDD methods. Register Now.

Cloud-Scale COVID-19 AI Research and Collaboration in Radiology
Recorded on Tuesday, June 29, 2021 | Flywheel & Imbio

Learn how a small, investigator-initiated project developed into a valuable COVID-19 chest CT dataset using Flywheel's research data management platform. You will also hear how Imbio is exploring the correlation between lung injury severity and patient prognosis, as well as developing AI to diagnose COVID-19. Digital transformation professionals, radiologists, data scientists, and clinical and translational imaging leads should attend to learn about integrating radiology research and AI solutions to enable collaboration and improve R&D efficiency. Register now. 

To De-Risk Your Next Trial, Seek Outside Expertise

Expert committee assessments provide validation on clinical data as additional support for regulatory submissions and commercial strategy. When establishing expert scientific committees to provide oversight on study data, independent expertise is essential. Without independent expertise, sponsors risk biased decision-making, conflicts of interest, potential clinical delays and squandered resources that could otherwise be avoided. Learn more.

Getting from R&D to IND - Pitfalls to avoid and how to succeed
Monday, June 28, 2021 | 1pm ET / 10am PT | Thermo Fisher Scientific

The road to IND isn’t always easy. Balancing speed, risk, and future needs is a challenge. Join Paul Jorjorian, Vice President and General Manager, Thermo Fisher Scientific, and learn how you can take your molecule from discovery to FiH trials without undue risk or excessive timelines. Plus, find out how you can meet short-term goals while preparing for future commercialization success. Register Now.

How to deal with a difficult-to-micronize drug substance
Recorded on Thursday, June 24, 2021 | Lonza

This webinar focuses on manufacturing aspects that enable successful development and scale-up of the micronization process. Technical issues that must be investigated for successful development of effective API micronization will be explored. An overview of micronization and typical scale-up challenges will be presented along with a robust process development strategy to ensure critical-to-quality attributes are maintained. Register Now.

Cell & Gene Therapy in 2040: Seizing the moment to propel the industry forward
PA Consulting

In this report, we explain how cell and gene therapy (C&GT) is translating into reality. The market is thriving with innovation, investment, partnerships and M&A activity. But much remains unclear about how these therapies can deliver full value, and where pharma and biotech leaders should invest energy and resources. This report will consider key topics such as early research, clinical trials, manufacturing and supply chain, regulations, reimbursement, and commercialization. Download now.

Essential up-front planning for your clinical trial
Monday, June 21, 2021 | 11am ET / 8am PT | Thermo Fisher Scientific

Early planning of your clinical supply chain is critical to ensuring programs effectively balance risk and cost. Uncover the benefits and best practices in this webinar to progress your clinical program smoothly from start to finish. Register Now.

Tenders for the Win: A Strategy to Secure Bids and Increase Revenue
Thursday, June 17, 2021 | 10am ET / 7am PT | Model N

Life Sciences manufacturers that focus on streamlining the tendering and bidding process win more. Join our tender experts for a virtual session to learn strategies to optimize your bids, streamline processes, and improve collaboration and visibility across the tender lifecycle. You’ll also hear from Veronica Gil, Pricing & Tender Director, Baxter EMEA, on how her team leveraged technology to centralize processes and develop a winning tender strategy. Register Now.

Accelerating NASH Clinical Trials
Tuesday, June 15, 2021 | 10am ET / 7am PT | Covance by Labcorp

Nearly a quarter of adults worldwide are thought to have non-alcoholic fatty liver disease; between 11% and 40% of them will progress to non-alcoholic steatohepatitis (NASH). Join industry leaders for a webinar dedicated to overcoming key challenges presented in NASH drug development. We’ll explore key considerations for liver biopsy collection and interpretation, emerging non-invasive biomarkers, and the connection between clinical practice and drug development. Register now.

Use of PBPK Modeling for Predicting and Optimizing Controlled Release Dosage Forms
Recorded on Monday, June 14, 2021 | Catalent

Join this webinar to hear experts share how dissolution tools and PBPK modeling can help evaluate whether a molecule is suitable for controlled release applications and predict the effects of release rate on in vitro performance. In addition, the experts will cover all aspects of oral controlled release technologies and discuss current strategies to select the optimal technology to meet the intended release profile. Register Now.

The Virtual Sales Rep: Using AI-Powered Bots to Enhance HCP Reach and Engagement
Recorded on Thursday, June 10, 2021 | Orbita

Healthcare is becoming more virtual and digital healthcare tools more common, which presents new challenges and opportunities for pharma sales. In response, brands are turning to innovative digital solutions to enhance and augment sales, including intelligent bots powered by conversational AI that can automate and augment HCP education and support. In this session, you’ll hear from leading agency experts working to transform HCP experiences with conversational AI voice and chatbots. Register Now.

Testing transformation: How the rapid shift to point-of-care is reshaping diagnostics
Thermo Fisher Scientific

COVID-19 has changed the diagnostic testing industry as a whole. A need for decentralized, easier, accurate, and rapid testing has never been more apparent. This whitepaper explores recent transformation and future of the point-of-care molecular diagnostics industry as a result of the pandemic, as well as assay development challenges/considerations for diagnostic test developers and new areas of application aside from infectious disease—oncology, non-invasive prenatal testing, inhered disease, and more. Download now.

Roundtable: The present and future of Cell & Gene Therapy, a perspective from innovators in the Québec ecosystem
Recorded on Wednesday, June 9, 2021 | Quebec Ministere Des Relations

Optimizing the manufacture and delivery of significant amounts of therapeutically potent cells, extend today’s frontiers in the field of cell therapy and regenerative medicine. Leaders in the pharma and biotech industry, health care sector and life science researchers will get insights about the latest advances in regenerative medicine, gene editing platforms, tackling the critical limitations in developing CRISPR therapeutics and more. Register Today

Vaccine Development Lessons From COVID – How the Ultra-Fast Development Process Could Be Applied to Other Diseases
Recorded on Tuesday, June 8, 2021 | Thermo Fisher Scientific

Before COVID-19, the typical vaccine took more than five years to develop. Biopharma companies raced from virus discovery to phase 3 testing of their COVID-19 vaccines in under a year. Now the industry is asking an important question: Can we take what we learned from COVID-19 vaccine successes and use it to speed up the development of other vaccines? Register now.

Key Ingredients for Your Security Framework
Monday, June 7, 2021 | 2pm ET / 11am PT | Fortinet

Large or small, cyberattacks are making headlines and elevating executive attention toward cyber resiliency. During this session, we will explore security considerations for developing cyber resilience covering security fundamentals and readiness planning to protect your IT and OT environments. Register now.

How the rapid shift to point-of-care is reshaping diagnostics
Thermo Fisher Scientific

The COVID-19 pandemic transformed the point-of-care (POC) diagnostic industry. Technologies that were on the periphery before the crisis such as isothermal amplification have become critical to the fight against the coronavirus, thus validating their potential through real-world use and accelerating adoption. The impact is extending well beyond COVID-19, with the crisis driving transitions to POC oncology, prenatal, and inherited disease testing. Faced with rapid change, test developers in this field are seeking out reliable suppliers of high-performing OEM components to keep up with the everchanging landscape. Learn more.

Roundtable: Clinical Trials - Optimizing Diversity, Equity and Inclusivity
Thursday, June 3, 2021 | 10am ET / 7am PT | ConcertAI

The recently heightened awareness of racial discrimination coupled with COVID-19’s disproportionate toll on disadvantaged communities has spurred the need for change. Yet the lack of equity and representation of minority groups in clinical research has been an open concern for decades. Attendees will learn how to optimize patient diversity and inclusivity of clinical trials. Register Now.

ASCO Explained: Expert predictions for the world's biggest cancer meeting
June 3, 2021 2 p.m. EST / 11 a.m. PST | Virtual Roundtable | Fierce Biotech

As we head into ASCO weekend, cancer experts will highlight closely watched data sets to be unveiled at the meeting. This discussion will take a close look at oncology's hottest fields, including CAR-T and precision medicine, as panelists zero in on the conference's most highly anticipated studies, 2021's biggest research trends, and the data they're most looking forward to seeing. Register now.

Manufacturing Human iPSCs and Derivatives under cGMPs for Clinical Applications
Wednesday, June 2, 2021 | 2pm ET / 9am PT | STEMCELL Technologies & Cedars-Sinai

Learn how human pluripotent stem cells (hPSCs) are being manufactured at scale for clinical applications under current Good Manufacturing Practices (cGMPs) from Dr. Dhruv Sareen, the Executive Director of the Cedars-Sinai Biomanufacturing Center. Register Now.

Improving Patient Adherence and Compliance With Innovative Digital Healthcare Solutions
Wednesday, June 2, 2021 | Aptar Pharma

When patients self-administer their medications, 60% do not take them as intended and over half of all patients are non-adherent. The resulting cost of non-adherence and non-optimized therapy is steep and everyone pays the price. The rules around healthcare engagement are now being rewritten, and technology has the potential to augment patient care, deliver value across the digital health ecosystem, and deliver better outcomes for all stakeholders in a more connected future. Register now.

Paid Marketplace
New Janssen Lung Data to be Featured at ASCO
The Janssen Pharmaceutical Companies of Johnson & Johnson

Janssen to highlight data from study of investigational bispecific antibody in patients with advanced non-small cell lung cancer with a certain genetic mutation. Click here to learn more. 

Paid Marketplace
HOOKIPA advances new, potent arenaviral immunotherapy class
June 7, 2021 | 6:30 pm EDT | HOOKIPA Pharma Inc.

Join us to review the first-in-human Phase 1 study of novel arenaviral therapeutics, HB-201 & HB-202, in advanced HPV16+ cancer patients (ASCO oral #2502). The program will highlight antigen-specific CD8+ T cell, anti-tumor activity and tolerability data, as well as implications for the future. Read more. 

Signaling Pathway CDx for Therapy Response Prediction
Wednesday, May 26, 2021 | QIAGEN

Learn how Philips and QIAGEN are using mRNA technology in OncoSignal tests to quantify functional activity of disease-relevant signal transduction pathways in any cell and tissue type. This webinar will explore applications for both preclinical disease modeling and clinical measurement of response to targeted therapies and immunotherapies. Register now.

Getting Real at the FDA – The Changing Tide on Real-World Evidence in Drug Development
Wednesday, May 26, 2021 | 2pm ET / 11am PT | Egnyte

FDA is opening up to data gathered outside the hermetically sealed clinical trial setting as regulators recognize the need for a more flexible framework for evaluating treatments. As a new approach that requires significant investment, RWE use requires the right talent and technology. Where to find those resources and how to deploy them are some of the questions companies face. We’ll address these questions and more with the help of current practitioners in the field. Register now.

Digitalization and the Future of Formulating in Modern R&D Labs
Recorded on Thursday, May 20, 2021 | Uncountable

Interested in digitizing your R&D organization, but not sure where to start? Looking to move from a wealth of spreadsheets and outdated software systems into one centralized data repository? This webinar shows what a modern software system should look like for R&D and how that compares to how most companies operate today. Register Today!

Closed Cell Processing System Benefits for Cell & Gene Therapy
Thermo Fisher Scientific

Autologous cell and gene therapy workflows involve isolating cells from an individual, engineering the cells, expanding and concentrating them, and infusing them back into the patient. Optimized automation of certain steps of the workflow may decrease hands-on time and the cost of the cell manufacturing process.  Learn more.

Oncology Biomarker Testing — Awareness, Drivers, and the Future
Recorded on Wednesday, May 19, 2021 | InCrowd

The field of oncology biomarker testing is growing rapidly. With so many new cancer treatments available requiring specific biomarkers for prescription, oncologists have plenty of new information to follow and many decisions to make when treating individual tumors. Register now.

Mitigating COVID-19 Risks in a Complex Pain Program - a Sponsor and CRO Perspective
Recorded on Wednesday, May 19, 2021 | Rho

UNITY Biotechnology partnered with Rho to execute a complex and fast-moving Osteoarthritis program with three concurrent clinical trials and database locks scheduled during the height of the COVID-19 pandemic. In this webinar, hear from both the Sponsor and CRO about the creative solutions they implemented and how they worked together to pivot quickly and meet critical study timelines in the midst of the pandemic. Register Now.

Roadmap Your Pharma OT Cybersecurity Strategy
Recorded on Thursday, May 13, 2021 | Honeywell

Learn actionable and real-world recommendations from Honeywell’s experienced ICS/OT cybersecurity team, as they reveal how they’ve coached both sites and enterprises to establish a resilient ICS/OT cybersecurity program. Register Now!

Enabling Text Mining for Business Users through Linguamatics Web Portals
Recorded on Thursday, May 6, 2021 | Linguamatics

Learn how Eli Lily put the power of text mining in the hands of primary (non-data-scientist) users through Linguamatics Web Portals. With the on-going information explosion, natural language processing (NLP)-based text mining has become important to gain meaning effectively from unstructured text. Register now.